These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11500255)

  • 1. Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study.
    Dinan TG; Scott LV; Thakore J; Naesdal J; Keeling PW
    Psychoneuroendocrinology; 2001 Oct; 26(7):751-6. PubMed ID: 11500255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects.
    Meltzer HY; Maes M
    Biol Psychiatry; 1994 Mar; 35(5):316-23. PubMed ID: 8011800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?
    Dinan TG; Mahmud N; Rathore O; Thakore J; Scott LV; Carr E; Naesdal J; O'Morain CA; Keeling PW
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1613-8. PubMed ID: 11564001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity?
    Condren RM; Dinan TG; Thakore JH
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):349-54. PubMed ID: 12126875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers.
    Anderson IM; Deakin JF; Miller HE
    Psychopharmacology (Berl); 1996 Nov; 128(1):74-82. PubMed ID: 8944409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of central serotonin sensitivity in breast cancer survivors with cancer-related fatigue syndrome.
    Alexander S; Stone P; White S; Andrews P; Nussey S; Bano G
    J Pain Symptom Manage; 2010 Dec; 40(6):892-8. PubMed ID: 20832986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V; Venitz J
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prolactin response to buspirone in chronic fatigue syndrome.
    Sharpe M; Clements A; Hawton K; Young AH; Sargent P; Cowen PJ
    J Affect Disord; 1996 Nov; 41(1):71-6. PubMed ID: 8938208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin response to buspirone challenge in the presence of dopaminergic blockade.
    Maskall DD; Zis AP; Lam RW; Clark CM; Kuan AJ
    Biol Psychiatry; 1995 Aug; 38(4):235-9. PubMed ID: 8547445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin response to buspirone was reduced in violent compared to nonviolent parolees.
    Cherek DR; Moeller FG; Khan-Dawood F; Swann A; Lane SD
    Psychopharmacology (Berl); 1999 Feb; 142(2):144-8. PubMed ID: 10102766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hydrocortisone on brain 5-HT function and sleep.
    Young AH; Sharpley AL; Campling GM; Hockney RA; Cowen PJ
    J Affect Disord; 1994 Oct; 32(2):139-46. PubMed ID: 7829766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1A autoreceptor.
    McAllister-Williams RH; Massey AE; Fairchild G
    J Psychopharmacol; 2007 Nov; 21(8):826-32. PubMed ID: 17715208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal response to buspirone is not impaired in major depression.
    Navinés R; Gómez-Gil E; Martín-Santos R; de Osaba MJ; Escolar G; Gastó C
    Hum Psychopharmacol; 2007 Aug; 22(6):389-95. PubMed ID: 17563921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of buspirone on perceived exertion and time to fatigue in man.
    Marvin G; Sharma A; Aston W; Field C; Kendall MJ; Jones DA
    Exp Physiol; 1997 Nov; 82(6):1057-60. PubMed ID: 9413736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.
    McAllister-Williams RH; Massey AE
    Psychopharmacology (Berl); 2003 Mar; 166(3):284-93. PubMed ID: 12589521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human motoneurone excitability is depressed by activation of serotonin 1A receptors with buspirone.
    D'Amico JM; Butler AA; Héroux ME; Cotel F; Perrier JM; Butler JE; Gandevia SC; Taylor JL
    J Physiol; 2017 Mar; 595(5):1763-1773. PubMed ID: 27859267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment.
    Gómez-Gil E; Navinés R; Martínez De Osaba MJ; Díaz-Ricart M; Escolar G; Salamero M; Martín-Santos R; Galán A; Gastó C
    Psychoneuroendocrinology; 2010 May; 35(4):481-9. PubMed ID: 19762159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of cortisol on spontaneous and 5HT stimulated prolactin release in man.
    Dinan TG; Scott LV
    J Basic Clin Physiol Pharmacol; 1996; 7(1):45-56. PubMed ID: 8983335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers.
    Porter RJ; Gallagher P; Watson S; Lunn BS; Young AH
    Psychopharmacology (Berl); 2002 Aug; 163(1):68-75. PubMed ID: 12185402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.